Skip to main navigation Skip to search Skip to main content

DMPK hypermethylation in sperm cells of myotonic dystrophy type 1 patients

  • Shira Yanovsky-Dagan
  • , Eliora Cohen
  • , Pauline Megalli
  • , Gheona Altarescu
  • , Oshrat Schonberger
  • , Talia Eldar-Geva
  • , Silvina Epsztejn-Litman
  • , Rachel Eiges*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Myotonic dystrophy type 1 (DM1) is an autosomal dominant muscular dystrophy that results from a CTG expansion (50–4000 copies) in the 3′ UTR of the DMPK gene. The disease is classified into four or five somewhat overlapping forms, which incompletely correlate with expansion size in somatic cells of patients. With rare exception, it is affected mothers who transmit the congenital (CDM1) and most severe form of the disease. Why CDM1 is hardly ever transmitted by fathers remains unknown. One model to explain the almost exclusive transmission of CDM1 by affected mothers suggests a selection against hypermethylated large expansions in the germline of male patients. By assessing DNA methylation upstream to the CTG expansion in motile sperm cells of four DM1 patients, together with availability of human embryonic stem cell (hESCs) lines with paternally inherited hypermethylated expansions, we exclude the possibility that DMPK hypermethylation leads to selection against viable sperm cells (as indicated by motility) in DM1 patients.

Original languageEnglish
Pages (from-to)980-983
Number of pages4
JournalEuropean Journal of Human Genetics
Volume30
Issue number8
DOIs
StatePublished - Aug 2022

Bibliographical note

Publisher Copyright:
© 2021, The Author(s).

Fingerprint

Dive into the research topics of 'DMPK hypermethylation in sperm cells of myotonic dystrophy type 1 patients'. Together they form a unique fingerprint.

Cite this